Form 8-K - Current report:
SEC Accession No. 0000950123-00-010212
Filing Date
2000-11-09
Accepted
2000-11-09 00:00:00
Documents
2
Period of Report
2000-11-09
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 OSI PHARMACEUTICALS, INC. y42372e8-k.txt 8-K 3449
2 PRESS RELEASE DATED NOVEMBER 9, 2000 y42372ex99.txt EX-99 8577
  Complete submission text file 0000950123-00-010212.txt   13899
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-15190 | Film No.: 757155
SIC: 2835 In Vitro & In Vivo Diagnostic Substances